Integrated Development and Manufacturing for Complex Bioconjugation

As bioconjugation expands beyond conventional antibody-drug conjugates into increasingly complex modalities, integrated development and manufacturing capabilities are becoming increasingly important. In this webinar, Samsung Biologics will share its approach to supporting bioconjugation programs through integrated development, manufacturing, analytical, and formulation capabilities at a single site. The presentation will highlight experience across multiple conjugation technologies and modalities as well as case example demonstrating process scale-up and transfer from laboratory development to GMP manufacturing. Attendees will also gain insights into the analytical and CMC considerations that support bioconjugated products throughout development.

Key Takeaways

• Integrated development and manufacturing for complex bioconjugates
• Process scale-up and transfer to GMP manufacturing
• Analytical and CMC considerations across development